Biphenyl

Biphenyl

SCHEMBL7633644

C1CCc2nnnn2CC1.c1ccc(-c2ccccc2)cc1

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.73
MEN1 O00255 4/20 0.73
KMT2A Q03164 4/20 0.73
MAPT P10636 2/20 0.73
BLM P54132 1/20 0.73
HPGD P15428 5/20 0.50
KDM4E B2RXH2 4/20 0.48
NPC1 O15118 2/20 0.48
LMNA P02545 2/20 0.48
HTT P42858 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
TRPV1 Q8NER1 1/20 0.42
POLB P06746 1/20 0.41
WDR5 P61964 2/20 0.40
HSD11B1 P28845 4/20 0.39
RAB9A P51151 1/20 0.39
HSD11B2 P80365 3/20 0.38
HDAC6 Q9UBN7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pentylenetetrazol SCHEMBL9838533 0.86 ALDH1A1 (1.00) ALDH1A1MEN1KMT2AMAPTBLM
Pentylenetetrazol SCHEMBL22674 0.86 ALDH1A1 (1.00) ALDH1A1MEN1KMT2AMAPTBLM
Pentylenetetrazol SCHEMBL6407957 0.86 ALDH1A1 (1.00) ALDH1A1MEN1KMT2AMAPTBLM
SCHEMBL3182039 0.86 ALDH1A1 (1.00) ALDH1A1MEN1KMT2AMAPTBLM
Pentylenetetrazol SCHEMBL10873243 0.84 ALDH1A1 (0.96) ALDH1A1MEN1KMT2AMAPTBLM
Pentylenetetrazol SCHEMBL15057132 0.84 ALDH1A1 (0.96) ALDH1A1MEN1KMT2AMAPTBLM
Pentylenetetrazol SCHEMBL10408117 0.84 ALDH1A1 (0.96) ALDH1A1MEN1KMT2AMAPTBLM
Pentylenetetrazol SCHEMBL28442995 0.84 ALDH1A1 (0.96) ALDH1A1MEN1KMT2AMAPTBLM
SCHEMBL2211329 0.84
SCHEMBL2212322 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6340772-B2 AROMATIZATION OF CYCLOHEXENONE DERIVATIVES VIA (CHLORO)CYCLOHEXADIENE NIPPON KAYAKU CO., LTD. (JP) 2002-01-22 US disclosed
US-20010020112-A1 Process for preparing (hetero) aromatic substituted benzene derivatives TOYA TETSUYA (JP) 2001-09-06 US disclosed
US-6271418-B1 AROMATIZATION OF CYCLOHEXENONE DERIVATIVES VIA (CHLORO)CYCLOHEXADIENE DERIVATIVES. NIPPON KAYAKU CO., LTD. (JP) 2001-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010020112-A1 Process for preparing (hetero) aromatic substituted benzene derivatives AHR, CYP3A4, CYP4B1 ALDH1A1 1596/4885MEN1 4245/4885KMT2A 2559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.